InspireMD, Inc. — Capital/Financing Update 2017

Mar 22, 2017

8-K 1 form8-k.htm

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

Field: Rule-Page

Field: /Rule-Page

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Field: Rule-Page

Field: /Rule-Page

Date of Report (Date of earliest event reported): March 21, 2017

InspireMD, Inc.

Field: Rule-Page

Field: /Rule-Page

(Exact name of registrant as specified in its charter)

Delaware	001-35731	26-2123838
(State
or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification
No.)

| 4 Menorat Hamaor St. Tel

Aviv, Israel	6744832
(Address
of principal executive offices)	(Zip
Code)

Registrant’s telephone number, including area code: (888) 776-6804

Field: Rule-Page

Field: /Rule-Page

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

| [ ] | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | | --- | --- | | [ ] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | | [ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | | [ ] | Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4(c)) |

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1; Options: NewSection

Field: /Page

Item 1.02 Termination of a Material Definitive Agreement.

On March 21, 2017, InspireMD, Inc. (the “Company”) paid down the remaining $1.2 million balance under the Company’s Loan and Security Agreement (the “Loan Agreement”), dated as of October 23, 2013, with Hercules Technology Growth Capital, Inc. (“Hercules”). All liens and other security interests granted to Hercules by the Company and its subsidiaries in connection with the Loan Agreement were terminated upon such payment. The key terms of the Loan Agreement and the amendments to the Loan Agreement were disclosed on the Company’s Current Reports on Form 8-K, filed with the Securities and Exchange Commission on October 25, 2013 and June 14, 2016, respectively.

Item 8.01 Other Events.

On March 22, 2017, the Company announced its repayment of the remaining balance on the Loan Agreement with Hercules. A copy of the press release announcing these events is attached as Exhibit 99.1 to this Current Report on Form 8-K and is hereby incorporated by reference herein.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

| Exhibit

Number	Description
99.1	Press release, dated March 22, 2017

Field: Page; Sequence: 2

Field: /Page

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

| InspireMD, Inc. — By: | /s/ Craig Shore | | --- | --- | | Name: | Craig Shore | | Title: | Chief Financial Officer |

Field: Page; Sequence: 3

Field: /Page